Kite Pharma, Inc. Insider Trading for February 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Kite Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Kite Pharma, Inc. for February 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 0.70 | 9,632 | 6,742 | 62,743 | |
| Feb 19 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 46.01 | 100 | 4,601 | 9,098 | 9.2 K to 9.1 K (-1.09 %) |
| Feb 19 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 45.05 | 9,532 | 429,417 | 9,198 | 18.7 K to 9.2 K (-50.89 %) |
| Feb 19 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 0.70 | 9,632 | 6,742 | 18,730 | 9.1 K to 18.7 K (+105.87 %) |
| Feb 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Option Exercise | M | 1.35 | 9,567 | 12,915 | 104,330 | |
| Feb 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 46.01 | 100 | 4,601 | 8,741 | 8.8 K to 8.7 K (-1.13 %) |
| Feb 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 45.07 | 9,467 | 426,678 | 8,841 | 18.3 K to 8.8 K (-51.71 %) |
| Feb 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Buy | M | 1.35 | 9,567 | 12,915 | 18,308 | 8.7 K to 18.3 K (+109.45 %) |
| Feb 18 2016 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Option Exercise | M | 6.89 | 9,000 | 62,010 | 16,000 | |
| Feb 18 2016 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Option Exercise | A | 6.89 | 25,000 | 172,250 | 25,000 | |
| Feb 18 2016 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Sell | S | 44.47 | 1,388 | 61,724 | 13,742 | 15.1 K to 13.7 K (-9.17 %) |
| Feb 18 2016 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Sell | S | 44.00 | 7,612 | 334,928 | 15,130 | 22.7 K to 15.1 K (-33.47 %) |
| Feb 18 2016 | KITE | Kite Pharma, Inc. | Wiezorek Jeffrey | SVP Clinical Develo ... | Buy | M | 6.89 | 9,000 | 62,010 | 22,742 | 13.7 K to 22.7 K (+65.49 %) |
| Feb 16 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Option Exercise | M | 0.70 | 18,750 | 13,125 | 72,375 | |
| Feb 16 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Sell | S | 64.16 | 18,750 | 1,202,964 | 9,098 | 27.8 K to 9.1 K (-67.33 %) |
| Feb 16 2016 | KITE | Kite Pharma, Inc. | Roberts Margo R | Chief Scientific Of ... | Buy | M | 0.70 | 18,750 | 13,125 | 27,848 | 9.1 K to 27.8 K (+206.09 %) |
| Feb 04 2016 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Option Exercise | M | 1.35 | 1,900 | 2,565 | 325,394 | |
| Feb 04 2016 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Sell | S | 50.13 | 1,900 | 95,247 | 94,007 | 95.9 K to 94 K (-1.98 %) |
| Feb 04 2016 | KITE | Kite Pharma, Inc. | BUTITTA CYNTHIA M | COO and CFO | Buy | M | 1.35 | 1,900 | 2,565 | 95,907 | 94 K to 95.9 K (+2.02 %) |
| Feb 03 2016 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Option Exercise | M | 0.38 | 9,000 | 3,420 | 60,000 | |
| Feb 03 2016 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Sell | S | 49.20 | 153 | 7,528 | 7,688 | 7.8 K to 7.7 K (-1.95 %) |
| Feb 03 2016 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Sell | S | 48.47 | 1,410 | 68,343 | 7,841 | 9.3 K to 7.8 K (-15.24 %) |
| Feb 03 2016 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Sell | S | 47.38 | 4,938 | 233,962 | 9,251 | 14.2 K to 9.3 K (-34.80 %) |
| Feb 03 2016 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Sell | S | 46.50 | 2,499 | 116,204 | 14,189 | 16.7 K to 14.2 K (-14.97 %) |
| Feb 03 2016 | KITE | Kite Pharma, Inc. | Better Marc | VP, Product Science ... | Buy | M | 0.38 | 9,000 | 3,420 | 16,688 | 7.7 K to 16.7 K (+117.07 %) |